| 2025-02-12 | +19.9% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2024-05-01 | -19.2% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2026-01-26 | -14.2% | analyst | Yahoo Finance | Are Wall Street Analysts Predicting CVS Health Stock Will Climb or Sink? - Yahoo Finance |
| 2026-01-27 | -12.1% | news | Yahoo Finance | Why CVS Health (CVS) Shares Are Plunging Today - Yahoo Finance |
| 2024-10-18 | -8.9% | legal | SEC EDGAR | CVS 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2022-10-06 | -8.4% | legal | SEC EDGAR | CVS 8-K: 8.01 (SEC Filing) |
| 2024-12-10 | -8.1% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2021-05-04 | +7.5% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2022-11-02 | +6.9% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2023-02-08 | +6.7% | legal | SEC EDGAR | CVS 8-K: 1.01 and (SEC Filing) |
| 2023-02-08 | +6.7% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2021-05-18 | +6.6% | legal | SEC EDGAR | CVS 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-06 | +5.9% | news | Stock Titan | May 6 webcast: CVS Health to detail first-quarter 2026 results - Stock Titan |
| 2026-04-06 | +5.9% | news | Benzinga | CVS, UnitedHealth, Humana, Elevance Shares Surge: Here's Why - UnitedHealth Group (NYSE:UNH) - Benzinga |
| 2026-02-26 | +5.9% | news | Seeking Alpha | Trump administration to hold back $259M in Medicaid payments to Minnesota |
| 2025-10-29 | -5.7% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2025-10-29 | -5.7% | earnings | Yahoo Finance | CVS Health tops Q3 forecasts but absorbs hefty charge for struggling clinic business - Yahoo Finance |
| 2025-08-15 | +5.4% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2022-08-03 | +5.3% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2026-04-07 | +4.9% | news | Seeking Alpha | Managed care rebounds after Medicare rate decision |
| 2026-04-07 | +4.9% | news | Seeking Alpha | Industry group says health plans have cut 11% of prior authorizations |
| 2026-04-07 | +4.9% | news | Seeking Alpha | Insurance stocks jump on Medicare Advantage rate boost: Humana, UnitedHealth, lead gains |
| 2026-04-07 | +4.9% | news | Benzinga | CVS Stock Rises After CMS Medicare Advantage Update - CVS Health (NYSE:CVS) - Benzinga |
| 2026-04-07 | +4.9% | news | Fast Company | Health insurance stocks: UnitedHealth Group, CVS, and Humana are rising on Medicare Advantage news - Fast Company |
| 2026-04-07 | +4.9% | news | StocksToTrade | CVS Stock Climbs on Optimistic Medicare Payment Updates - StocksToTrade |
| 2021-08-04 | -4.8% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2024-12-05 | -4.8% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2022-08-02 | +4.7% | legal | SEC EDGAR | CVS 8-K: 8.01 (SEC Filing) |
| 2022-02-09 | -4.6% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2026-01-20 | +4.6% | news | Yahoo Finance | How CVS Health’s Dividend And Medicare Focus At CVS (CVS) Has Changed Its Investment Story - Yahoo Finance |
| 2026-04-13 | -4.4% | news | The Motley Fool | Should You Buy CVS Health Stock Before May 6? - The Motley Fool |
| 2026-04-13 | -4.4% | news | Yahoo Finance | CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance |
| 2026-04-13 | -4.4% | news | MarketWatch | CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch |
| 2024-11-18 | +4.1% | legal | SEC EDGAR | CVS 8-K: 1.01, 5.02, 7.01 (SEC Filing) |
| 2023-05-03 | -4.1% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2025-08-29 | +4.0% | news | Yahoo Finance | CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance |
| 2023-05-25 | -3.9% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2026-02-07 | -3.8% | news | The Motley Fool | Should You Buy CVS Health Stock Before Feb. 10? - The Motley Fool |
| 2026-02-09 | -3.6% | news | Yahoo Finance | CVS Health Corporation (CVS) Under Pressure From Medicare Proposal, Argus Holds Positive View - Yahoo Finance |
| 2026-01-28 | +3.6% | news | Forbes | Is CVS Stock The Best Of The Worst? - Forbes |
| 2026-01-28 | +3.6% | news | Trefis | What’s Behind The Crash In CVS Stock? - Trefis |
| 2026-02-05 | +3.5% | news | The Motley Fool | Is CVS Health Stock a Bad-News Buy? - The Motley Fool |
| 2023-05-02 | -3.4% | legal | SEC EDGAR | CVS 8-K: 1.01, 2.03, 2.04, 8.01 (SEC Filing) |
| 2025-11-11 | +3.2% | earnings | Yahoo Finance | CVS Health Lifts Adjusted EPS Outlook: What's Driving It? - Yahoo Finance |
| 2026-02-23 | -3.0% | earnings | Yahoo Finance | Assessing CVS Health (NYSE:CVS) Valuation After Recent Share Pullback And Earnings Charges - Yahoo Finance |
| 2026-03-10 | -3.0% | news | Seeking Alpha | Extra premiums due to alleged Medicare overpayments topped $13B in 2025: WSJ |
| 2026-03-09 | -2.8% | news | Seeking Alpha | CVS Health Corporation (CVS) Presents at Leerink Global Healthcare Conference 2026 Transcript |
| 2026-03-09 | -2.8% | news | Seeking Alpha | Top 10 healthcare stocks with highest dividend yield amid volatile markets |
| 2025-12-09 | +2.6% | earnings | Barron's | CVS Health Stock Gains on Guidance Raise. How It Expects to Perform in 2025 and Beyond. - Barron's |
| 2025-12-09 | +2.6% | earnings | CNBC | CVS forecasts 2026 profit above estimates as turnaround plan takes effect - CNBC |
| 2025-12-09 | +2.6% | news | Yahoo Finance | Why CVS Health (CVS) Stock Is Up Today - Yahoo Finance |
| 2026-03-17 | -2.6% | news | Yahoo Finance | CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance |
| 2021-11-03 | +2.6% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2026-04-12 | -2.5% | news | Yahoo Finance | CVS Health Corporation (CVS): Legal Clarity and Core Strengths Support the Bull Case - Yahoo Finance |
| 2025-11-20 | +2.5% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2024-08-07 | -2.5% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2022-05-04 | +2.4% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2025-10-16 | +2.4% | news | Yahoo Finance | CVS Health Corporation (CVS): A Must-Buy Dividend Stock Leading U.S. Pharmacy and Healthcare - Yahoo Finance |
| 2025-10-16 | +2.4% | news | Yahoo Finance | Here's Why CVS Health (CVS) is a Strong Momentum Stock - Yahoo Finance |
| 2025-10-16 | +2.4% | earnings | Yahoo Finance | Should You Add CVS Health Stock to Your Portfolio Before Q3 Earnings? - Yahoo Finance |
| 2021-08-09 | +2.4% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2026-03-04 | -2.4% | news | Seeking Alpha | Rising employee health insurance costs dampened wage growth: Fed survey |
| 2026-03-04 | -2.4% | news | Yahoo Finance | Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know - Yahoo Finance |
| 2026-03-04 | -2.4% | analyst | Investing.com | Truist Securities reiterates Buy rating on CVS Health stock at $98 - Investing.com |
| 2026-04-08 | -2.3% | news | Seeking Alpha | CVS Health: A Diversified Income Play With Improving MA Rate Visibility For 2027 |
| 2026-04-08 | -2.3% | legal | Newswire.com | LAWSUIT UPDATE: Investors in CVS Health Corporation (NYSE: CVS) Shares Should Contact the Shareholders Foundation in Connection with Pending Lawsuit - Newswire.com |
| 2026-04-08 | -2.3% | news | Seeking Alpha | CVS Health: A Diversified Income Play With Improving MA Rate Visibility For 2027 - Seeking Alpha |
| 2026-03-18 | -2.3% | earnings | Stock Titan | CVS Health sets May 4 payout for 66.5-cent quarterly dividend - Stock Titan |
| 2025-07-31 | +2.3% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2021-08-23 | -2.3% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2023-01-23 | -2.2% | legal | SEC EDGAR | CVS 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-09-22 | +2.2% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2023-08-02 | +2.2% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2026-04-15 | -2.1% | news | Yahoo Finance | Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock - Yahoo Finance |
| 2026-04-15 | -2.1% | news | MarketWatch | CVS Health Corp. stock underperforms Wednesday when compared to competitors - MarketWatch |
| 2026-04-15 | -2.1% | news | MSN | CVS Health Corporation (CVS) is a trending stock: Facts to know before betting on it - MSN |
| 2023-11-01 | -2.1% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2022-09-13 | +2.1% | legal | SEC EDGAR | CVS 8-K: 5.02 (SEC Filing) |
| 2025-09-01 | +2.0% | news | Yahoo Finance | Can CVS Health Corporation's (NYSE:CVS) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price? - Yahoo Finance |
| 2026-02-10 | +1.9% | news | Seeking Alpha | CVS Health: Why Margin Compression In Aetna Limits The Upside For 2026 |
| 2026-02-10 | +1.9% | earnings | Seeking Alpha | CVS Health reaffirms $7–$7.20 EPS target for 2026 while advancing cost-based pharmacy model |
| 2026-02-10 | +1.9% | earnings | Seeking Alpha | CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript |
| 2026-02-10 | +1.9% | earnings | Seeking Alpha | CVS Health Corporation 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-10 | +1.9% | news | Seeking Alpha | CVS Health, Centene, Elevance among insurers to receive House panel subpoenas: Axios |
| 2026-02-10 | +1.9% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2026-02-10 | +1.9% | news | TIKR.com | Here’s Why CVS Health Stock Could Continue Its 40% Rally - TIKR.com |
| 2026-02-10 | +1.9% | news | PR Newswire | CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS - PR Newswire |
| 2026-02-10 | +1.9% | earnings | ChartMill | CVS Health Corp (NYSE:CVS) Beats Q4 Estimates but Shares Dip on Cautious Outlook - ChartMill |
| 2026-02-10 | +1.9% | earnings | Investing.com | CVS Health Corp earnings beat by $0.09, revenue topped estimates - Investing.com |
| 2024-05-22 | -1.9% | legal | SEC EDGAR | CVS 8-K: 5.02, 5.07 (SEC Filing) |
| 2021-08-11 | +1.7% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2023-01-09 | -1.7% | legal | SEC EDGAR | CVS 8-K: 2.02 (SEC Filing) |
| 2021-08-18 | -1.6% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2026-04-16 | +1.6% | news | Yahoo Finance | Jim Cramer Shares Big Advantage For CVS Health Corporation (CVS) - Yahoo Finance |
| 2026-04-16 | +1.6% | analyst | MarketWatch | CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-02-17 | -1.6% | earnings | Finviz | The Top 5 Analyst Questions From CVS Health's Q4 Earnings Call - Finviz |
| 2026-04-23 | +1.6% | news | TheStreet | CVS fights law that could force over 100 stores to close |
| 2026-04-23 | +1.6% | news | simplywall.st | Is It Too Late To Consider CVS Health (CVS) After Last Year’s 24% Share Price Gain - simplywall.st |
| 2026-04-23 | +1.6% | news | NAI500 | CVS Health’s Transformation Is Underestimated by the Market, with Three Major Reasons Highlighting Its Value Stock Potential - NAI500 |
| 2026-04-23 | +1.6% | news | GuruFocus | CVS Health Corp (CVS) Shares Surge 3.2% -- What GF Score of 83 T - GuruFocus |
| 2026-04-23 | +1.6% | earnings | TIKR.com | CVS Health Q4 2025 Earnings: Strong Pharmacy Numbers, One Big Insurance Drag - TIKR.com |
| 2026-04-23 | +1.6% | analyst | MarketWatch | CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch |
| 2022-03-10 | +1.6% | legal | SEC EDGAR | CVS 8-K: 5.02 and (SEC Filing) |
| 2023-07-20 | +1.6% | legal | SEC EDGAR | CVS 8-K: 5.02 (SEC Filing) |
| 2026-03-02 | +1.6% | news | Yahoo Finance | How Is CVS Health’s Stock Performance Compared to Other Healthcare Stocks? - Yahoo Finance |
| 2026-03-02 | +1.6% | news | Stock Titan | CVS (CVS) EVP Samrat Khichi surrenders 7,886 shares for tax withholding - Stock Titan |
| 2026-01-21 | +1.6% | news | Finviz | Should You Buy CVS Health Stock Before Feb. 10? - Finviz |
| 2026-01-21 | +1.6% | news | The Motley Fool | Should You Buy CVS Health Stock Before Feb. 10? - The Motley Fool |
| 2025-10-23 | -1.5% | news | Yahoo Finance | Why CVS Health (CVS) is a Top Value Stock for the Long-Term - Yahoo Finance |
| 2023-09-21 | +1.5% | legal | SEC EDGAR | CVS 8-K: 5.02 (SEC Filing) |
| 2021-12-13 | +1.5% | legal | SEC EDGAR | CVS 8-K: 8.01 (SEC Filing) |
| 2023-06-02 | +1.4% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2026-03-05 | -1.4% | expansion | Seeking Alpha | CVS launches Health100 backed by Google Clouds AI tech |
| 2025-12-11 | +1.4% | legal | Yahoo Finance | Jim Cramer on CVS: “This Stock Has Become the Best Performer in the Healthcare Sector” - Yahoo Finance |
| 2026-02-18 | -1.4% | news | Seeking Alpha | Medicare Advantage growth reportedly slows down as UnitedHealth, CVS retreat |
| 2026-02-18 | -1.4% | news | Yahoo Finance | CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance |
| 2024-01-05 | -1.4% | legal | SEC EDGAR | CVS 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2024-12-02 | -1.3% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2026-04-22 | +1.3% | news | Zacks | CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know |
| 2026-04-22 | +1.3% | news | Trefis | How UNH Stock Is Trading Short-Term Margins For Long-Term Moats |
| 2026-04-22 | +1.3% | news | Motley Fool | Is CVS Health the Ultimate Value Stock to Buy Right Now? |
| 2026-04-22 | +1.3% | news | The Motley Fool | Is CVS Health the Ultimate Value Stock to Buy Right Now? - The Motley Fool |
| 2026-04-22 | +1.3% | news | Yahoo Finance | CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance |
| 2026-03-11 | +1.3% | news | Seeking Alpha | CVS Health to pay $117.7M to settle Medicare fraud allegations |
| 2026-01-22 | +1.3% | news | TIKR.com | Here’s Why CVS Health Stock Could Continue Rising in 2026 After 50% Gains Last Year - TIKR.com |
| 2026-04-17 | -1.3% | news | Seeking Alpha | Dividend Roundup: Johnson & Johnson, Costco, Caterpillar, CVS Health, and more |
| 2022-11-21 | +1.2% | legal | SEC EDGAR | CVS 8-K: 5.03, 8.01 (SEC Filing) |
| 2022-03-25 | -1.2% | legal | SEC EDGAR | CVS 8-K: 5.02 and (SEC Filing) |
| 2022-03-30 | -1.2% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2025-04-08 | +1.1% | legal | SEC EDGAR | CVS 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-23 | +1.1% | analyst | Yahoo Finance | Bernstein Upgrades CVS Health (CVS) Stock to Outperform from Market Perform - Yahoo Finance |
| 2025-07-25 | +1.1% | news | Yahoo Finance | Here's Why CVS Health (CVS) is a Strong Value Stock - Yahoo Finance |
| 2026-01-09 | -1.1% | news | Yahoo Finance | Jim Cramer Reveals How CVS Health Corporation (CVS) is “Saving a Lot of Money” - Yahoo Finance |
| 2026-02-03 | +1.1% | news | TIKR.com | CVS Stock Climbed 35% Last Year. Is It Still a Buy in 2026? - TIKR.com |
| 2025-05-01 | -1.1% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2026-01-14 | +1.1% | news | Yahoo Finance | Could CVS Health Corporation's (NYSE:CVS) Weak Financials Mean That The Market Could Correct Its Share Price? - Yahoo Finance |
| 2024-12-06 | -1.1% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2026-01-06 | -1.1% | news | Stock Titan | CVS Health will pay shareholders 66.5 cents per share in February - Stock Titan |
| 2025-11-28 | -1.0% | analyst | Yahoo Finance | CVS Health Stock: Is CVS Outperforming the Healthcare Sector? - Yahoo Finance |
| 2026-03-24 | +1.0% | news | Seeking Alpha | CVS Health rises after six-session losing streak |
| 2026-03-24 | +1.0% | news | Seeking Alpha | CVS Health settles FTC case over insulin pricing |
| 2025-09-30 | +1.0% | legal | Yahoo Finance | Bank of America Securities Maintains a Buy on CVS Health Corporation (CVS) - Yahoo Finance |
| 2026-03-25 | -1.0% | legal | Seeking Alpha | CVS Health's Discounted Buying Opportunity Is Here - Robust Fundamentals And Secure Dividends |
| 2026-03-25 | -1.0% | news | TIKR.com | CVS Health Stock Forecast: 11% Annual Returns Despite Margin Pressure - TIKR.com |
| 2024-05-09 | +1.0% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2026-04-20 | +0.9% | legal | DirectorsTalk Interviews | CVS Health Corporation (CVS) Stock Analysis: Navigating a 24.94% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews |
| 2024-02-07 | +0.9% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2025-12-31 | +0.9% | news | Yahoo Finance | Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock - Yahoo Finance |
| 2025-09-25 | -0.9% | news | Yahoo Finance | Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term - Yahoo Finance |
| 2025-12-29 | +0.8% | analyst | Yahoo Finance | Where is CVS Health Corporation (CVS) Headed According to Analysts? - Yahoo Finance |
| 2026-04-04 | -0.8% | analyst | Seeking Alpha | Insurers to receive extra $18B as Medicare overhauls Star Ratings system |
| 2026-04-04 | -0.8% | news | Yahoo Finance | If You'd Invested $100 in CVS Health (CVS) Stock 5 Years Ago, Here's How Much You'd Have Today (Spoiler: You Wouldn't Have Lost Money) - Yahoo Finance |
| 2024-05-08 | -0.7% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2025-11-10 | -0.7% | earnings | Stock Titan | CVS Health (NYSE: CVS) to outline 2025–2026 guidance at Investor Day with webcast - Stock Titan |
| 2023-02-21 | +0.6% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2024-12-09 | +0.6% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2026-01-16 | +0.6% | earnings | Yahoo Finance | CVS Health Corporation (CVS) Board Approves Quarterly Dividend As Cantor Fitzgerald and Bernstein Assert Bullishness - Yahoo Finance |
| 2024-12-17 | +0.5% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2026-04-21 | -0.5% | news | TradingKey | CVS Health Corp Stock (CVS) Opened Up by 3.02% on Apr 21: Key Drivers Unveiled - TradingKey |
| 2026-04-21 | -0.5% | news | Barchart | Slow-Moving CVS Health (CVS) Stock Could Offer a Surprise for Bullish Options Traders - Barchart |
| 2026-04-21 | -0.5% | earnings | GuruFocus | CVS Stock Rises Following UnitedHealth's Quarterly Announcement - GuruFocus |
| 2026-04-21 | -0.5% | earnings | Barchart | Here's What to Expect From CVS Health's Next Earnings Report - Barchart |
| 2026-04-02 | +0.5% | news | Stock Titan | CVS Health (CVS) grants options and RSUs to EVP Prem Shah - Stock Titan |
| 2026-04-02 | +0.5% | news | Stock Titan | CVS (CVS) EVP Tilak Mandadi receives stock options, RSUs and surrenders shares for taxes - Stock Titan |
| 2026-04-02 | +0.5% | executive | Stock Titan | CVS (CVS) CEO Joyner receives large RSU grant and surrenders shares for taxes - Stock Titan |
| 2026-04-02 | +0.5% | news | Stock Titan | CVS Health (NYSE: CVS) grants options and RSUs to EVP Capozzi - Stock Titan |
| 2026-04-02 | +0.5% | executive | Stock Titan | CVS (CVS) CFO Brian Newman receives new stock options and RSU awards - Stock Titan |
| 2026-04-02 | +0.5% | news | Stock Titan | CVS Health (NYSE: CVS) grants options and RSUs to top legal executive - Stock Titan |
| 2026-04-02 | +0.5% | news | Yahoo Finance | CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance |
| 2026-04-02 | +0.5% | analyst | MarketWatch | CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-04-02 | +0.5% | news | Stock Titan | [Form 4] CVS HEALTH Corp Insider Trading Activity - Stock Titan |
| 2026-02-15 | -0.5% | news | Yahoo Finance | CVS Health Corporation (NYSE:CVS) is favoured by institutional owners who hold 88% of the company - Yahoo Finance |
| 2026-02-14 | -0.5% | earnings | Seeking Alpha | Earnings Scorecard: Healthcare sector shows strong top-line pulse |
| 2022-07-15 | +0.5% | legal | SEC EDGAR | CVS 8-K: 8.01 (SEC Filing) |
| 2022-01-11 | -0.5% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2023-06-01 | +0.5% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2023-02-15 | +0.4% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2022-10-20 | -0.4% | legal | SEC EDGAR | CVS 8-K: 8.01 (SEC Filing) |
| 2023-10-16 | -0.4% | legal | SEC EDGAR | CVS 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-05-16 | +0.3% | legal | SEC EDGAR | CVS 8-K: 8.01 (SEC Filing) |
| 2025-09-19 | +0.3% | news | Yahoo Finance | Why CVS Health (CVS) is a Top Value Stock for the Long-Term - Yahoo Finance |
| 2026-04-09 | +0.2% | news | Seeking Alpha | Whats next for health insurance stocks after the Medicare Advantage rate boost? |
| 2022-09-06 | -0.2% | legal | SEC EDGAR | CVS 8-K: 8.01 and (SEC Filing) |
| 2022-09-06 | -0.2% | legal | SEC EDGAR | CVS 8-K: 1.01 and (SEC Filing) |
| 2026-03-19 | -0.2% | news | Seeking Alpha | Many individuals have not renewed ACA coverage after subsidy expiration |
| 2026-03-19 | -0.2% | news | Seeking Alpha | CVS declares $0.665 dividend |
| 2026-03-19 | -0.2% | legal | SEC EDGAR | CVS 8-K: 5.02 (SEC Filing) |
| 2026-03-19 | -0.2% | news | Yahoo Finance | CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance |
| 2024-11-06 | -0.2% | legal | SEC EDGAR | CVS 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-11-06 | -0.2% | legal | SEC EDGAR | CVS 8-K: 2.02 and (SEC Filing) |
| 2026-03-20 | -0.1% | news | Seeking Alpha | Medicare Advantage payments in focus as regulator says insurers yet to rein in costs |
| 2026-03-20 | -0.1% | news | Seeking Alpha | Dividend Roundup: JPMorgan Chase, Micron Technology, CVS Health, Broadcom, and more |
| 2026-03-20 | -0.1% | news | Stock Titan | CVS (CVS) director John Gallina granted 582 shares as semi-annual retainer - Stock Titan |
| 2025-10-07 | -0.1% | news | Yahoo Finance | Here's Why CVS Health (CVS) is a Strong Value Stock - Yahoo Finance |
| 2026-03-06 | -0.1% | news | Seeking Alpha | CVS Health: Stop Catastrophizing, Start Believing - Here's Why |
| 2026-03-06 | -0.1% | news | Seeking Alpha | CVS Health: Stop Catastrophizing, Start Believing - Here's Why (NYSE:CVS) - Seeking Alpha |
| 2025-09-04 | +0.1% | analyst | Yahoo Finance | Is CVS Health Stock Outperforming the Dow? - Yahoo Finance |
| 2026-01-10 | -0.1% | news | Yahoo Finance | CVS Health Corporation (NYSE:CVS) is a favorite amongst institutional investors who own 89% - Yahoo Finance |
| 2021-06-10 | -0.0% | legal | SEC EDGAR | CVS 8-K: 5.02 and (SEC Filing) |
| 2026-04-27 | — | news | Simply Wall St. | Assessing CVS Health (CVS) Valuation After Recent Share Price Momentum And Mixed Signals |
| 2026-04-26 | — | news | Insider Monkey | Jim Cramer on CVS Health: “I Think It’s Only Going to Get Better as the Competition Disappears” |
| 2026-04-26 | — | news | Yahoo Finance | Jim Cramer on CVS Health: “I Think It’s Only Going to Get Better as the Competition Disappears” - Yahoo Finance |
| 2026-04-24 | — | news | The Wall Street Journal | U.S. Health Insurers Step Up Prior Authorization Reforms |
| 2026-04-24 | — | news | MT Newswires | CVS Health's Aetna Says 88% of Prior Authorization Volume Standardized |
| 2026-04-24 | — | news | Packaging Dive | Packaging innovations: CVS Health swaps foam, PPG coats pet food cans |
| 2026-04-24 | — | news | PR Newswire | Aetna Announces Progress on Industry Leading Efforts to Simplify Prior Authorization |
| 2026-04-24 | — | news | Seeking Alpha | UnitedHealth, CVS Health tout efforts to standardize prior authorizations |
| 2026-04-24 | — | news | MarketWatch | CVS Health Corp. stock underperforms Friday when compared to competitors - MarketWatch |
| 2026-04-24 | — | news | Stock Titan | Aetna says 95% of eligible care approvals clear within 24 hours - Stock Titan |
| 2026-04-24 | — | news | Reuters | US health insurers advance measures to standardize prior authorization requirements - Reuters |